Tranylcypromine
Monoamine Oxidase Inhibitors, Non-Selective
Sold as PARNATE
- Drug class
- Monoamine Oxidase Inhibitors, Non-Selective
- Availability
- See label
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 24
Overview
Tranylcypromine is an active pharmaceutical ingredient in the Monoamine Oxidase Inhibitors, Non-Selective group (N06AF). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 22 | May 27, 2026 |
| CA Canada | Health Canada | 2 | March 22, 2025 |
GBUnited Kingdom· MHRA
22 products
Uses
Tranylcypromine is indicated for the treatment of Major Depressive Episodes in adult patients when treatment with other types of antidepressant medication has failed.
How to take
CACanada· Health Canada
2 products
Uses
PARNATE (tranylcypromine sulfate) is indicated for the treatment of major depressive disorder (MDD) in adult patients who have not responded adequately to other antidepressants. PARNATE is not indicated for the initial treatment of MDD due to the potential for serious adverse reactions and drug interactions, and the need for dietary restrictions.
Pediatrics Pediatrics (<18 years of age):
PARNATE is not indicated for use in children or adolescents less than 18 years of age.
Geriatrics Geriatrics:
No data are available.
How to take
Drug interactions
Known interactions involving Tranylcypromine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 459. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL204160968 · revised January 9, 2026
- [2]Health Canada (DPD) · 01919598 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.